Prostatis Group’s Vanguard Intermediate-Term Bond ETF BIV Stock Holding History
Bought
Maintained
Sold
Other funds holding BIV
EWA
TLFA
Prostatis Group's BIV Position: Q2 2026 in Review
Prostatis Group reduced its Vanguard Intermediate-Term Bond ETF (BIV) stake by 4.8% in Q2 2026, selling an estimated $209K and leaving 54,214 shares worth $4.16M. The position accounts for 0.97% of the portfolio, ranked #28.
Prostatis Group first reported a position in BIV in Q4 2020 and has held it in 19 quarters since. The position peaked at $5.89M in Q1 2024. 1,019 funds tracked by Wall St. Rank hold BIV as of Q2 2026.
- Prostatis Group held 54,214 shares of Vanguard Intermediate-Term Bond ETF worth $4.16M as of Q2 2026.
- Prostatis Group sold 2,716 Vanguard Intermediate-Term Bond ETF shares in Q2 2026, an estimated $209K.
- Vanguard Intermediate-Term Bond ETF made up 0.97% of Prostatis Group's portfolio in Q2 2026, its #28 holding.
- Prostatis Group first reported a position in Vanguard Intermediate-Term Bond ETF in Q4 2020 and has held it in 19 quarters since.
- Prostatis Group's Vanguard Intermediate-Term Bond ETF position peaked at $5.89M in Q1 2024.
- 1,019 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Bond ETF as of Q2 2026.
Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.